Nadolol Drug Profile

What is Nadolol?

Nadolol is a non-selective beta-adrenergic blocking agent (beta-blocker) used primarily to treat high blood pressure and prevent chest pain caused by heart disease. Unlike some other beta-blockers, nadolol has a long duration of action, allowing for once-daily dosing in most patients. It belongs to a class of cardiovascular medications that work by blocking specific receptors in the heart and blood vessels.

Uses

Nadolol is FDA-approved and commonly prescribed for several cardiovascular conditions:

• Hypertension (high blood pressure): Used alone or in combination with other antihypertensive medications to lower blood pressure and reduce cardiovascular risk
• Angina pectoris: Helps prevent chest pain episodes caused by reduced blood flow to the heart muscle
• Migraine prevention: Used off-label to reduce the frequency and severity of migraine headaches
• Arrhythmia management: May be prescribed to help control certain irregular heart rhythms
• Essential tremor: Sometimes used off-label to reduce involuntary shaking, particularly in the hands

How it works

Nadolol blocks both beta-1 and beta-2 adrenergic receptors throughout the body, which are normally activated by stress hormones like adrenaline. By blocking these receptors in the heart, nadolol reduces heart rate and the force of heart contractions, thereby lowering blood pressure and reducing the heart’s oxygen demand. In blood vessels, this blocking action helps prevent constriction and promotes more stable blood flow.

Side effects

Common side effects include:

Submit Your Paper

• Fatigue and weakness
• Dizziness or lightheadedness
• Cold hands and feet
• Slow heart rate (bradycardia)
• Nausea
• Sleep disturbances or vivid dreams
• Decreased exercise tolerance
• Depression or mood changes

Serious side effects requiring immediate medical attention:

• Severe breathing difficulties or wheezing
• Signs of heart failure (swelling, severe shortness of breath)
• Extremely slow or irregular heartbeat
• Severe dizziness or fainting
• Signs of low blood sugar in diabetic patients

Warnings and precautions

• Respiratory conditions: Patients with asthma, chronic obstructive pulmonary disease (COPD), or other breathing disorders should avoid nadolol, as it can worsen respiratory symptoms
• Heart conditions: Use with extreme caution in patients with heart failure, heart block, or very slow heart rates
• Diabetes: May mask signs of low blood sugar and can affect glucose control; diabetic patients require closer monitoring
• Pregnancy: Classified as FDA Pregnancy Category C; should only be used when potential benefits outweigh risks to the fetus
• Kidney function: Dosage adjustments are necessary in patients with reduced kidney function, as nadolol is primarily eliminated through the kidneys
• Sudden discontinuation: Should not be stopped abruptly, as this can cause rebound high blood pressure or heart problems

Interactions

Nadolol can interact with numerous medications and substances:

• Calcium channel blockers (verapamil, diltiazem): Can cause dangerously low heart rate and blood pressure
• Insulin and diabetes medications: May enhance blood sugar-lowering effects and mask hypoglycemia symptoms
• NSAIDs (ibuprofen, naproxen): Can reduce nadolol’s blood pressure-lowering effectiveness
• Digoxin: Combined use may lead to excessive slowing of heart rate
• Clonidine: If both are discontinued, clonidine should be stopped first to prevent rebound hypertension
• Epinephrine: May cause severe high blood pressure and slow heart rate
• Alcohol: Can enhance blood pressure-lowering effects and increase dizziness risk
• Anesthetics: May enhance the cardiovascular depressant effects during surgery

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated. For hypertension, the usual starting dose is 40-80 mg once daily, which may be increased gradually to 80-320 mg daily as needed. For angina prevention, doses typically range from 40-240 mg once daily. The long half-life of nadolol allows for convenient once-daily dosing in most patients. Dosage adjustments are required for patients with kidney impairment, and elderly patients may need lower starting doses. All dosing decisions should be individualized and determined by a healthcare provider based on patient response, tolerance, and specific medical conditions.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).